Compare · head to head
Handok vs Yuhan
Yuhan ranks higher overall — 360 rank 32 vs 15.
Handok leads on Value (51 vs 37) and Quality (52 vs 30). Yuhan leads on Safety (59 vs 16) and Sentiment (54 vs 40).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | South Korea |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Small | Medium |
| ISIN | KR7002390003 | KR7000100008 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 15 | 32 |
| Value | 51 | 37 |
| Quality | 52 | 30 |
| Growth | NR | 51 |
| Safety | 16 | 59 |
| Sentiment | 40 | 54 |
| Quality details | ||
| Profitability | 52 | 32 |
| Cash Truth | 51 | 27 |
Handok vs Chunghwa Chemical Synthesis & BiotechHandok vs Green CrossHandok vs Dong-A STHandok vs PharmGen ScienceAdd a third stock →
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100